Craft

Advanced
  • Home
  •  / Stereotaxis
Stereotaxis

Stereotaxis

Stock Price

$2

2024-10-29

Market Capitalization

$165.1 M

2024-10-29

Revenue

$32.4 M

FY, 2025

Stereotaxis Summary

Company Summary

Overview
Stereotaxis is a developer of robotic cardiology systems. It offers robotic magnetic navigation systems for performing endovascular procedures, robotically navigated ablation catheters, and procedure monitoring software. The company caters to physicians, hospitals, and caregivers.
Type
Public
Status
Active
Founded
1990
HQ
St. Louis, MO, US | view all locations
Website
https://www.stereotaxis.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Nathan Fischel, Director

    • David W. Benfer, Lead Independent Director

      • David Fischel, Chief Executive Officer and Chairman of the Board

        • Arun Menawat, Director

          LocationsView all

          2 locations detected

          • St. Louis, MO HQ

            United States

            710 N Tucker Blvd Suite 110

          • Amsterdam, NH

            Netherlands

            Teleport Towers, Kingsfordweg 151

          Stereotaxis Financials

          Summary Financials

          Revenue (Q1, 2026)
          $6.3M
          Gross profit (Q1, 2026)
          $3.8M
          Net income (Q1, 2026)
          ($5.9M)
          Cash (Q1, 2026)
          $14.6M
          EBIT (Q1, 2026)
          ($6.0M)
          Enterprise value
          $155.7M

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX